BO
TRIB

BRR OpCo’s Trinity Biotech TRIB Stock Holding History

BRR OpCo’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-94
Closed -$79K – 109
2017
Q3 		$79K Buy
+94
New +$78.7K 0.02% 102

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

BRR OpCo's TRIB Position: Q4 2017 in Review

BRR OpCo sold out of Trinity Biotech (TRIB) in Q4 2017, closing a stake of 94 shares — an estimated $79K sold.

BRR OpCo first reported a position in TRIB in Q3 2017 and held it in 1 quarter. The position peaked at $79K in Q3 2017. 47 funds tracked by Wall St. Rank hold TRIB as of Q4 2017.

  • BRR OpCo reported no remaining Trinity Biotech position as of Q4 2017 after selling out during the quarter.
  • BRR OpCo sold 94 Trinity Biotech shares in Q4 2017, an estimated $79K.
  • BRR OpCo first reported a position in Trinity Biotech in Q3 2017 and held it in 1 quarter.
  • BRR OpCo's Trinity Biotech position peaked at $79K in Q3 2017.
  • 47 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2017.

Based on BRR OpCo's 13F filing for Q4 2017, filed 13 Feb 2018.